Sharat Chandra

1.7k total citations
37 papers, 343 citations indexed

About

Sharat Chandra is a scholar working on Hematology, Immunology and Epidemiology. According to data from OpenAlex, Sharat Chandra has authored 37 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 20 papers in Immunology and 7 papers in Epidemiology. Recurrent topics in Sharat Chandra's work include Hematopoietic Stem Cell Transplantation (15 papers), Immunodeficiency and Autoimmune Disorders (13 papers) and Immune Cell Function and Interaction (10 papers). Sharat Chandra is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Immunodeficiency and Autoimmune Disorders (13 papers) and Immune Cell Function and Interaction (10 papers). Sharat Chandra collaborates with scholars based in United States, Germany and Netherlands. Sharat Chandra's co-authors include Stella M. Davies, Rebecca Marsh, Parinda A. Mehta, Michael Grimley, Michael B. Jordan, Pooja Khandelwal, Ashish Kumar, Jack Bleesing, Kasiani C. Myers and Alexander A. Vinks and has published in prestigious journals such as Journal of Biological Chemistry, Frontiers in Immunology and Transplantation.

In The Last Decade

Sharat Chandra

35 papers receiving 342 citations

Peers

Countries citing papers authored by Sharat Chandra

Since Specialization

Citations

This map shows the geographic impact of Sharat Chandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharat Chandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharat Chandra more than expected).

Fields of papers citing papers by Sharat Chandra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharat Chandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharat Chandra. The network helps show where Sharat Chandra may publish in the future.

Co-authorship network of co-authors of Sharat Chandra

This figure shows the co-authorship network connecting the top 25 collaborators of Sharat Chandra. A scholar is included among the top collaborators of Sharat Chandra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharat Chandra. Sharat Chandra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Age Impacts Risk of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Non-Severe Combined Immune Deficiency Inborn Errors of Immunity 2023 ·Transplantation and Cellular Therapy ·(unknown), Adam Lane, (unknown), Jack Bleesing, Michael B. Jordan, Ashish Kumar, Pooja Khandelwal, (unknown), Rebecca Marsh, Sharat Chandra	2
2	HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh 2022 ·Blood Advances ·Shanmuganathan Chandrakasan, Sharat Chandra, Chengyu Prince, Lisa Kobrynski, (unknown), Kiran Patel, Jolán E. Walter, Rebecca H. Buckley, Roland Meisel, Sujal Ghosh, Suhag Parikh	2
3	Primary Immunodeficiencies and Hematologic Malignancies: A Diagnostic Approach 2022 ·Frontiers in Immunology ·Sharat Chandra, (unknown), Nicola Wright, Blachy J. Dávila Saldaña	8
4	Daratumumab Is Safe and Effective for the Treatment of Refractory Autoimmunity in Children 2021 ·Transplantation and Cellular Therapy ·Ashley Teusink‐Cross, Rebecca Marsh, Stella M. Davies, Michael B. Jordan, (unknown), Jack Bleesing, Ashish Kumar, Parinda A. Mehta, Sharat Chandra, Pooja Khandelwal	0
5	Ruxolitinib for the Treatment of Chronic GVHD in Children and Young Adults 2021 ·Transplantation and Cellular Therapy ·(unknown), Ashley Teusink‐Cross, Kasiani C. Myers, Stella M. Davies, Ashish Kumar, Sharat Chandra, Michael Grimley, (unknown), (unknown), (unknown), (unknown), Parinda A. Mehta, Pooja Khandelwal	1
6	Test‐dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non‐malignant disorders 2021 ·British Journal of Clinical Pharmacology ·Sharat Chandra, Kana Mizuno, Junfang Zhao, Stella M. Davies, Rebecca Marsh, Tsuyoshi Fukuda, Kenneth D.R. Setchell, Alexander A. Vinks, Parinda A. Mehta	6
7	A prospective pilot study of a novel alemtuzumab target concentration intervention strategy 2021 ·Bone Marrow Transplantation ·Danielle E. Arnold, Chie Emoto, Tsuyoshi Fukuda, Min Dong, Alexander A. Vinks, Adam Lane, (unknown), Lisa Neumeier, Arjan C. Lankester, (unknown), Ashley Teusink‐Cross, Sharat Chandra, Michael B. Jordan, (unknown), Kasiani C. Myers, Stella M. Davies, Parinda A. Mehta, Rebecca Marsh	6
8	Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation 2020 ·Journal of Clinical Immunology ·Sharat Chandra, Shanmuganathan Chandrakasan, Blachy J. Dávila Saldaña, Jack Bleesing, Michael B. Jordan, Ashish Kumar, Michael Grimley, Christa Krupski, Stella M. Davies, Pooja Khandelwal, Rebecca Marsh	13
9	Non-Tuberculous Mycobacterial Infection in Hematopoietic Cell Transplant 2020 ·Journal of Clinical Immunology ·Anthony Sabulski, Stella M. Davies, Grant Paulsen, Ashish Kumar, Michael Grimley, Sharat Chandra	2
10	CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study 2020 ·Bone Marrow Transplantation ·Pooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink‐Cross, Angela D. M. Kashuba, Adam Lane, Parinda A. Mehta, Rebecca Marsh, Michael B. Jordan, Michael Grimley, Kasiani C. Myers, Adam Nelson, Javier El‐Bietar, Sharat Chandra, (unknown), (unknown), Stella M. Davies	7
11	Post-Transplant CD34+ Selected Stem Cell “Boost” for Mixed Chimerism after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Children and Young Adults with Primary Immune Deficiencies 2018 ·Biology of Blood and Marrow Transplantation ·Sharat Chandra, Jack Bleesing, Michael B. Jordan, Michael Grimley, Pooja Khandelwal, Stella M. Davies, (unknown), Tom Leemhuis, Rebecca Marsh	10
12	Pretransplant Absolute Lymphocyte Counts Impact the Pharmacokinetics of Alemtuzumab 2017 ·Biology of Blood and Marrow Transplantation ·Rebecca Marsh, Tsuyoshi Fukuda, Chie Emoto, Lisa Neumeier, Pooja Khandelwal, Sharat Chandra, Ashley Teusink‐Cross, Alexander A. Vinks, Parinda A. Mehta	21
13	Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation 2017 ·Biology of Blood and Marrow Transplantation ·(unknown), Pooja Khandelwal, Sharat Chandra, Michael B. Jordan, Ashish Kumar, Michael Grimley, Stella M. Davies, Jack Bleesing, Rebecca Marsh	11
14	Intravenous Posaconazole is Safe and Effective in Pediatric HSCT Patients 2017 ·Biology of Blood and Marrow Transplantation ·Ashley Teusink‐Cross, Stella M. Davies, Sharat Chandra, Adam Lane, Parinda A. Mehta	6
15	Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation 2017 ·Clinical Pharmacokinetics ·Kana Mizuno, Min Dong, Tsuyoshi Fukuda, Sharat Chandra, Parinda A. Mehta, Scott A. McConnell, Elias Anaissie, Alexander A. Vinks	12
16	A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation 2016 ·Biology of Blood and Marrow Transplantation ·Pooja Khandelwal, Chie Emoto, Tsuyoshi Fukuda, Alexander A. Vinks, Lisa Neumeier, Christopher E. Dandoy, Javier El‐Bietar, Sharat Chandra, Stella M. Davies, (unknown), Michael B. Jordan, Parinda A. Mehta, Sonata Jodele, Michael Grimley, Ashish Kumar, Kasiani C. Myers, Rebecca Marsh	18
17	Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen 2015 ·Biology of Blood and Marrow Transplantation ·Rebecca Marsh, Marepalli B. Rao, (unknown), (unknown), Parinda A. Mehta, Pooja Khandelwal, Sharat Chandra, Sonata Jodele, Kasiani C. Myers, Michael Grimley, Christopher E. Dandoy, Javier El‐Bietar, Ashish Kumar, Tom Leemhuis, Kejian Zhang, Jack Bleesing, Michael B. Jordan, Alexandra H. Filipovich, Stella M. Davies	48
18	An Intermediate Alemtuzumab Schedule Reduces the Incidence of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis 2013 ·Biology of Blood and Marrow Transplantation ·Rebecca Marsh, Mi‐Ok Kim, Chunyan Liu, (unknown), Laura K. Hart, Michael Grimley, Ashish Kumar, Sonata Jodele, Kasiani C. Myers, Sharat Chandra, Tom Leemhuis, Parinda A. Mehta, Jack Bleesing, Stella M. Davies, Michael B. Jordan, Alexandra H. Filipovich	56
19	K-Cl Cotransporter Gene Expression during Human and Murine Erythroid Differentiation 2011 ·Journal of Biological Chemistry ·Dao Pan, Theodosia A. Kalfa, Daren Wang, Mary Risinger, Scott C. Crable, (unknown), Sharat Chandra, David B. Mount, Christian A. Hübner, Robert S. Franco, Clinton H. Joiner	21
20	EASTERN EQUINE ENCEPHALITIS VIRUS INFECTION AND HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A 5-MONTH-OLD INFANT 2009 ·The Pediatric Infectious Disease Journal ·(unknown), Hamayun Imran, Sharat Chandra, (unknown), (unknown), (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact